|
US20040219186A1
(en)
*
|
2001-08-16 |
2004-11-04 |
Ayres James W. |
Expandable gastric retention device
|
|
TWI312285B
(en)
*
|
2001-10-25 |
2009-07-21 |
Depomed Inc |
Methods of treatment using a gastric retained gabapentin dosage
|
|
AUPR951501A0
(en)
*
|
2001-12-14 |
2002-01-24 |
Smart Drug Systems Inc |
Modified sustained release pharmaceutical system
|
|
US20040192582A1
(en)
*
|
2002-12-19 |
2004-09-30 |
Burnett Daniel R. |
Ingestible formulations for transient, noninvasive reduction of gastric volume
|
|
US7554452B2
(en)
*
|
2003-07-18 |
2009-06-30 |
Cary Cole |
Ingestible tracking and locating device
|
|
EP1660153A2
(en)
*
|
2003-09-04 |
2006-05-31 |
The United States of America as represented by the Department of Veterans Affairs |
Hydrogel nanocompsites for ophthalmic applications
|
|
WO2005030179A1
(en)
*
|
2003-09-29 |
2005-04-07 |
Cj Corporation |
Sustained-release formulations
|
|
CA2549195A1
(en)
*
|
2003-12-09 |
2005-06-23 |
Spherics, Inc. |
Bioadhesive polymers with catechol functionality
|
|
US20080089933A1
(en)
|
2006-10-16 |
2008-04-17 |
Amir Alon |
Device and method for reducing calorie intake
|
|
US20050196355A1
(en)
*
|
2004-03-03 |
2005-09-08 |
Constantine Georgiades |
Film products having controlled disintegration properties
|
|
US8007827B2
(en)
*
|
2004-04-02 |
2011-08-30 |
Impax Laboratories, Inc. |
Pharmaceutical dosage forms having immediate release and/or controlled release properties
|
|
DE602005025755D1
(de)
|
2004-06-04 |
2011-02-17 |
Teva Pharma |
Irbesartan enthaltende pharmazeutische zusammensetzung
|
|
US20080311191A1
(en)
*
|
2004-08-27 |
2008-12-18 |
Avinash Nangia |
Multi-Layer Tablets and Bioadhesive Dosage Forms
|
|
MX2007007836A
(es)
*
|
2004-12-27 |
2007-08-20 |
Eisai R&D Man Co Ltd |
Metodo para estabilizar un farmaco anti-demencia.
|
|
US20060246003A1
(en)
*
|
2004-12-27 |
2006-11-02 |
Eisai Co. Ltd. |
Composition containing anti-dementia drug
|
|
US20070129402A1
(en)
*
|
2004-12-27 |
2007-06-07 |
Eisai Research Institute |
Sustained release formulations
|
|
US20060280789A1
(en)
*
|
2004-12-27 |
2006-12-14 |
Eisai Research Institute |
Sustained release formulations
|
|
IL166183A0
(en)
*
|
2005-01-06 |
2006-01-15 |
Yissum Res Dev Co |
Novel diagnostic and imaging techniques of the gi tract
|
|
WO2006088305A1
(en)
*
|
2005-02-15 |
2006-08-24 |
Chong Kun Dang Pharmaceutical Corp. |
Gastric-retentive controlled release mono-matrix tablet
|
|
EP1933811A2
(en)
*
|
2005-09-30 |
2008-06-25 |
Alza Corporation |
Banded controlled release nanoparticle active agent formulation dosage forms and methods
|
|
US20070092565A1
(en)
*
|
2005-10-25 |
2007-04-26 |
Pharmascience Inc. |
Gastric retention drug delivery system
|
|
EP2997953B1
(en)
*
|
2006-01-18 |
2018-12-26 |
Intec Pharma Ltd. |
Delivery device for oral intake of an agent
|
|
WO2007093999A1
(en)
*
|
2006-02-15 |
2007-08-23 |
Intec Pharma Ltd. |
A gastro-retentive system for the delivery of macromolecules
|
|
EP2086515A2
(en)
*
|
2006-03-02 |
2009-08-12 |
Vaunnex, Inc. |
Rate-controlled bioadhesive oral dosage formulations
|
|
PE20080669A1
(es)
*
|
2006-09-08 |
2008-07-18 |
Drugtech Corp |
Composicion de liberacion sostenida que comprende levodopa
|
|
EP2124884B1
(en)
|
2006-12-22 |
2019-07-10 |
Ironwood Pharmaceuticals, Inc. |
Compositions comprising bile acid sequestrants for treating esophageal disorders
|
|
WO2008115597A2
(en)
*
|
2007-03-21 |
2008-09-25 |
Cytologic, Inc. |
Cytokine muteins and methods for enhancing immune responses in mammals
|
|
US8961412B2
(en)
|
2007-09-25 |
2015-02-24 |
Proteus Digital Health, Inc. |
In-body device with virtual dipole signal amplification
|
|
WO2009064814A2
(en)
|
2007-11-12 |
2009-05-22 |
Pharmaceutics International, Inc. |
Tri-molecular complexes and their use in drug delivery systems
|
|
CN102149369B
(zh)
|
2008-04-18 |
2016-08-10 |
因泰克制药有限公司 |
卡比多巴/左旋多巴胃滞留给药
|
|
US7981760B2
(en)
*
|
2008-05-08 |
2011-07-19 |
Panasonic Corporation |
Method for manufacturing nonvolatile storage element and method for manufacturing nonvolatile storage device
|
|
US8287902B2
(en)
*
|
2008-07-23 |
2012-10-16 |
Rainbow Medical Ltd. |
Enhanced-diffusion capsule
|
|
CA2745741A1
(en)
|
2008-12-04 |
2010-06-10 |
Intec Pharma Ltd. |
Zaleplon gastroretentive drug delivery system
|
|
CN102481276A
(zh)
|
2009-04-20 |
2012-05-30 |
埃尔舍利克斯治疗公司 |
基于化学感受受体配体的治疗法
|
|
US8828953B2
(en)
*
|
2009-04-20 |
2014-09-09 |
NaZura BioHealth, Inc. |
Chemosensory receptor ligand-based therapies
|
|
US9901551B2
(en)
|
2009-04-20 |
2018-02-27 |
Ambra Bioscience Llc |
Chemosensory receptor ligand-based therapies
|
|
US8414559B2
(en)
*
|
2009-05-07 |
2013-04-09 |
Rainbow Medical Ltd. |
Gastroretentive duodenal pill
|
|
US20100286628A1
(en)
*
|
2009-05-07 |
2010-11-11 |
Rainbow Medical Ltd |
Gastric anchor
|
|
US20110066175A1
(en)
*
|
2009-05-07 |
2011-03-17 |
Rainbow Medical Ltd. |
Gastric anchor
|
|
EP2490677A2
(en)
*
|
2009-10-19 |
2012-08-29 |
Intec Pharma Ltd. |
Novel gastroretentive dosage forms of poorly soluble drugs
|
|
CN106913902A
(zh)
|
2009-11-09 |
2017-07-04 |
聚光灯技术合伙有限责任公司 |
多糖基水凝胶
|
|
CN102695501A
(zh)
|
2009-11-09 |
2012-09-26 |
聚光灯技术合伙有限责任公司 |
碎裂水凝胶
|
|
WO2011073968A1
(en)
*
|
2009-12-18 |
2011-06-23 |
Vysera Biomedical Limited |
A drug delivery system
|
|
ES2671551T3
(es)
|
2009-12-18 |
2018-06-07 |
Coloplast A/S |
Un biomaterial
|
|
EP2544666A2
(en)
|
2010-03-09 |
2013-01-16 |
Council of Scientific and Industrial Research |
Gastroretentive, extended release composition of therapeutic agent
|
|
US10010439B2
(en)
|
2010-06-13 |
2018-07-03 |
Synerz Medical, Inc. |
Intragastric device for treating obesity
|
|
US9526648B2
(en)
|
2010-06-13 |
2016-12-27 |
Synerz Medical, Inc. |
Intragastric device for treating obesity
|
|
US8628554B2
(en)
|
2010-06-13 |
2014-01-14 |
Virender K. Sharma |
Intragastric device for treating obesity
|
|
US10420665B2
(en)
|
2010-06-13 |
2019-09-24 |
W. L. Gore & Associates, Inc. |
Intragastric device for treating obesity
|
|
WO2012027331A1
(en)
|
2010-08-27 |
2012-03-01 |
Ironwood Pharmaceuticals, Inc. |
Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders
|
|
MX2013004364A
(es)
|
2010-10-19 |
2013-07-02 |
Elcelyx Therapeutics Inc |
Terapias a base de ligando del receptor quimiosensorial.
|
|
EP2661266B1
(en)
|
2011-01-07 |
2020-09-16 |
Anji Pharma (US) LLC |
Chemosensory receptor ligand-based therapies
|
|
US8722066B2
(en)
|
2011-03-29 |
2014-05-13 |
Primigenia, LLC |
Devices and methods for weight control and weight loss
|
|
US20130143867A1
(en)
|
2011-12-02 |
2013-06-06 |
Sychroneuron Inc. |
Acamprosate formulations, methods of using the same, and combinations comprising the same
|
|
WO2013158928A2
(en)
|
2012-04-18 |
2013-10-24 |
Elcelyx Therapeutics, Inc. |
Chemosensory receptor ligand-based therapies
|
|
WO2014039951A1
(en)
|
2012-09-10 |
2014-03-13 |
Novartis Ag |
Enteral pharmaceutical compositions
|
|
EP2988729A1
(en)
*
|
2013-04-25 |
2016-03-02 |
Sun Pharmaceutical Industries Limited |
Pharmaceutical gastro-retentive solid oral dosage form of nilotinib
|
|
WO2014197744A1
(en)
|
2013-06-05 |
2014-12-11 |
Synchroneuron, Inc. |
Acamprosate formulations, methods of using the same, and combinations comprising the same
|
|
WO2015091885A2
(en)
*
|
2013-12-20 |
2015-06-25 |
Fresenius Kabi Deutschland Gmbh |
Microcapsules with polymeric coating comprising a lipid and an active agent
|
|
WO2015187746A1
(en)
|
2014-06-02 |
2015-12-10 |
Teva Pharmaceutical Industries Ltd. |
Expandable gastroretentive dosage form
|
|
NZ727659A
(en)
|
2014-06-11 |
2021-12-24 |
Massachusetts Inst Technology |
Residence structures and related methods
|
|
US20170266112A1
(en)
|
2014-06-11 |
2017-09-21 |
Massachusetts Institute Of Technology |
Residence structures and related methods
|
|
US9492396B2
(en)
|
2014-07-15 |
2016-11-15 |
Yossi Gross |
Enhanced drug delivery pill
|
|
AU2016272089B2
(en)
*
|
2015-06-03 |
2021-02-18 |
Triastek, Inc. |
Dosage forms and use thereof
|
|
CN108721242B
(zh)
*
|
2015-06-03 |
2021-03-02 |
南京三迭纪医药科技有限公司 |
药品剂型及其使用
|
|
MX387092B
(es)
|
2015-06-17 |
2025-03-19 |
Biogen Ma Inc |
Particulas de dimetilfumarato y composiciones farmaceuticas de estas.
|
|
US11576859B2
(en)
|
2015-10-23 |
2023-02-14 |
Lyndra Therapeutics, Inc. |
Gastric residence systems for sustained release of therapeutic agents and methods of use thereof
|
|
US11478427B2
(en)
*
|
2015-10-26 |
2022-10-25 |
Aron H. Blaesi |
Dosage form comprising structural framework of two-dimensional elements
|
|
EP3368010B1
(en)
*
|
2015-10-26 |
2025-12-10 |
Blaesi, Aron H. |
Solid dosage form immediate drug release and apparatus and method for manufacture thereof
|
|
US11129798B2
(en)
|
2016-08-19 |
2021-09-28 |
Aron H. Blaesi |
Fibrous dosage form
|
|
CA3006999A1
(en)
*
|
2015-12-01 |
2017-06-08 |
Clexio Biosciences Ltd. |
Gastric retentive devices
|
|
CA3007165A1
(en)
*
|
2015-12-02 |
2017-06-08 |
Clexio Biosciences Ltd. |
Device for preparing gastroretentive dosage forms
|
|
WO2017100367A1
(en)
|
2015-12-08 |
2017-06-15 |
Lyndra, Inc. |
Geometric configurations for gastric residence systems
|
|
CA3017797A1
(en)
|
2016-03-17 |
2017-09-21 |
Thiogenesis Therapeutics, Inc. |
Compositions for controlled release of cysteamine and systemic treatment of cysteamine sensitive disorders
|
|
US10779980B2
(en)
|
2016-04-27 |
2020-09-22 |
Synerz Medical, Inc. |
Intragastric device for treating obesity
|
|
CN109310639A
(zh)
|
2016-05-27 |
2019-02-05 |
林德拉有限公司 |
用于胃驻留系统的材料结构
|
|
BR112018077541A2
(pt)
*
|
2016-07-11 |
2019-04-30 |
Intec Pharma Ltd. |
formulações orais gastrorretentivas e usos das mesmas
|
|
JP2019532947A
(ja)
|
2016-09-30 |
2019-11-14 |
リンドラ，インコーポレイティド |
アダマンタン系薬物の持続的送達のための胃内滞留システム
|
|
CN110035718B
(zh)
|
2016-12-02 |
2021-04-06 |
克雷西奥生物科技有限公司 |
胃内滞留系统
|
|
EP3573602A4
(en)
|
2017-01-26 |
2020-09-16 |
Triastek, Inc. |
DOSAGE FORMS OF CONTROLLED RELEASE AT SPECIFIC GASTROINTESTINAL SITES
|
|
CA3066658A1
(en)
|
2017-06-09 |
2018-12-13 |
Lyndra, Inc. |
Gastric residence systems with release rate-modulating films
|
|
CA3076392A1
(en)
|
2017-09-20 |
2019-03-28 |
Thiogenesis Therapeutics, Inc. |
Methods for the treatment of cysteamine sensitive disorders
|
|
WO2019111132A1
(en)
|
2017-12-04 |
2019-06-13 |
Clexio Biosciences Ltd. |
Long acting gastric residence system
|
|
CN116270513A
(zh)
|
2018-01-09 |
2023-06-23 |
南京三迭纪医药科技有限公司 |
一种包含固定剂量adhd非兴奋剂和adhd兴奋剂的复方口服药物剂型
|
|
US11911513B2
(en)
|
2018-05-23 |
2024-02-27 |
Shanghai Wd Pharmaceutical Co., Ltd |
Controlled-release system of active pharmaceutical ingredient and preparation method therefor
|
|
JP7125791B2
(ja)
|
2018-05-23 |
2022-08-25 |
シャンハイ ダブリュディー ファーマシューティカル カンパニー，リミティド |
活性薬物成分の放出制御システムおよびその製造方法
|
|
CN114191307A
(zh)
|
2020-09-17 |
2022-03-18 |
上海汉都医药科技有限公司 |
一种口腔滞留装置及其制备方法
|
|
US10675248B2
(en)
|
2018-08-14 |
2020-06-09 |
Alma Therapeutics Ltd. |
Expandable pill
|
|
HUE067496T2
(hu)
|
2020-12-08 |
2024-10-28 |
Ruminant Biotech Corp Ltd |
Az állatoknak szánt anyagok bejuttatására szolgáló eszközök és módszerek fejlesztése
|
|
KR20230159878A
(ko)
|
2021-05-20 |
2023-11-22 |
이 잉크 코포레이션 |
전기 도금을 사용하는 유익 제제 전달 시스템
|